Association of MIF-173G/C and MBL2 codon 54 gene polymorphisms with rheumatoid arthritis: A meta-analysis

Human Immunology

Volumn 73, Issue 9, 2012, Pages 966-971

  Xie, Qiang ^a,b   Wang, Shi Cun ^b   Bian, Geng ^b   Zhan, Feng Lin ^b   Xie, Ji Kui ^b   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN 2;

ASIA; CODON; DISEASE PREDISPOSITION; ETHNICITY; EXON; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; CODON; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MANNOSE-BINDING LECTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84865359670     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.07.043     Document Type: Review

References (46)

1. Karouzakis E., Neidhart M., Gay R.E., Gay S. Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett 2006, 106:8-13.
2. Okada Y., Terao C., Ikari K., Kochi Y., Ohmura K., Suzuki A., et al. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat Genet 2012, 44:511-516.
3. Zheng B., Li Q., Wei C., Qin J., Shou T., Zhou R., et al. Lack of association of TLR4 gene Asp299Gly and Thr399Ile polymorphisms with rheumatoid arthritis in Chinese Han population of Yunnan Province. Rheumatol Int 2010, 30:1249-1252.
4. Wordsworth B.P., Lanchbury J.S., Sakkas L.I., Welsh K.I., Panayi G.S., Bell J.I. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA classII region. Proc Natl Acad Sci 1989, 86:10049-10053.
5. Deighton C.M., Walker D.J., Griffiths I.D., Roberts D.F. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989, 36:178-182.
6. Radstake T.R., Fransen J., Toonen E.J., Coenen M.J., Eijsbouts A.E., Donn R., et al. Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis. Ann Rheum Dis 2007, 66:1525-1530.
7. de la Fontaine L., Schwarz M.J., Riedel M., Dehning S., Douhet A., Spellmann I., et al. Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusi ng on MIF and CD14 gene polymorphisms. Psychiatry Res 2006, 144:39-47.
8. Bacher M., Metz C.N., Calandra T., Mayer K., Chesney J., Lohoff M., et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996, 93:7849-7854.
9. Baugh J.A., Chitnis S., Donnelly S.C., Monteiro J., Lin X., Plant B.J., et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002, 3:170-176.
10. Calandra T., Bernhagen J., Metz C.N., Spiegel L.A., Bacher M., Donnelly T., et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995, 377:68-71.
11. Flaster H., Bernhagen J., Calandra T., Bucala R. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol Endocrinol 2007, 21:1267-1280.
12. Fingerle-Rowson G., Koch P., Bikoff R., Lin X., Metz C.N., Dhabhar F.S., et al. Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol 2003, 162:47-56.
13. Leech M., Metz C., Hall P., Hutchinson P., Gianis K., Smith M., et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of pro-inflammatory function and regulation by gluco-corticoids. Arthritis Rheum 1999, 42:1601-1608.
14. Martínez A., Orozco G., Varadé J. Sánchez López M, Pascual D, Balsa A, et al. Macrophage migration inhibitory factor gene: Influence on rheumatoid arthritis susceptibility. Hum Immunol 2007, 68:744-747.
15. Paralkar V., Wistow G. Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 1994, 19:48-51.
16. Budarf M., McDonald T., Sellinger B., Kozak C., Graham C., Wistow G. Localization of the human gene for macrophage migration inhibitory factor (MIF) to chromosome 22q11.2. Genomics 1997, 39:235-236.
17. Chang Y.Y., Greinix H.T., Dickinson A.M., Wolff D., Jackson G.H., Andreesen R., et al. G to C transition at position -173 of MIF gene of the recipient is associated with reduced relapse rates after allogeneic stem cell transplantation. Cytokine 2009, 48:218-225.
18. De Benedetti F., Meazza C., Vivarelli M., Rossi F., Pistorio A., Lamb R., et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2003, 48:1398-1407.
19. Lee Y.H., Lee H.S., Choi S.J., Ji J.D., Song G.G. The association between the mannose-binding lectin codon 54 polymorphism and systemic lupus erythematosus: a meta-analysis update. Mol Biol Rep 2012, 39:5569-5574.
20. Horiuchi T., Tsukamoto H., Morita C., Sawabe T., Harashima S., Nakashima H., et al. Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Genes Immun 2000, 1:464-466.
21. Gupta B., Agrawal C., Raghav S.K., Das S.K., Das R.H., Chaturvedi V.P., et al. Association of mannose-binding lectin gene (MBL2) polymorphisms with rheumatoid arthritis in an Indian cohort of case-control samples. J Hum Genet 2005, 50:583-591.
22. Corper A.L., Sohi M.K., Bonagura V.R., Steinitz M., Jefferis R., Feinstein A., et al. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat Struct Biol 1997, 5:374-381.
23. Bond A., Alavi A., Axford J.S., Youinou P., Hay F.C. The relationship between exposed galactose and N-acetylglucos-amine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjogren's syndrome (SS). Clin Exp Immunol 1996, 105:99-103.
24. Malhotra R., Wormald M.R., Rudd P.M., Fischer P.B., Dwek R.A., Sim R.B. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995, 1:237-243.
25. Parekh R.B., Dwek R.A., Sutton B.J., Fernandes D.L., Leung A., Stanworth D., et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985, 316:452-457.
26. Stanworth S.J., Donn R.P., Hassall A., Dawes P., Ollier W., Snowden N. Absence of an association between mannose-binding lectin polymorphism and rheumatoid arthritis. Br J Rheumatol 1998, 37:186-188.
27. Jakab L., Laki J., Sallai K., Temesszentandrási G., Pozsonyi T., Kalabay L., et al. Association between early onset and organ manifestations of systemic lupus erythematosus (SLE) and a down-regulating promoter polymorphism in the MBL2 gene. Clin Immunol 2007, 125:230-236.
28. Garred P., Larsen F., Madsen H.O., Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 2003, 40:73-84.
29. Palomino-Morales R., Gonzalez-Juanatey C., Vazquez-Rodriguez T.R., Torres O., Miranda-Filloy J.A., Llorca J., et al. Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain. Clin Exp Rheumatol 2010, 28:68-72.
30. Yang Z., Liang Y., Qin B., Li C., Zhong R. TLR9 polymorphisms and systemic lupus erythematosus risk in Asians: a meta-analysis study. Cytokine 2012, 57:282-289.
31. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
32. Lee Y.H., Nath S.K. Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Gene 2005, 118:434-443.
33. Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008, 358:900-909.
34. Honda K., Yanai H., Takaoka A., Taniguchi T. Regulation of the type I IFN induction: a current view. Int Immunol 2005, 17:1367-1378.
35. Zhang Y.G., Huang J., Zhang J., Li X.B., He C., Xiao Y.L., et al. RANTES gene polymorphisms and asthma risk: a meta-analysis. Arch Med Res 2010, 41:50-58.
36. Radstake T.R., Sweep F.C., Welsing P., Franke B., Vermeulen S.H., Geurts-Moespot A., et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005, 52:3020-3029.
37. Ip W.K., Lau Y.L., Chan S.Y., Mok C.C., Chan D., Tong K.K., et al. Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum 2000, 43:1679-1687.
38. Tsutsumi A., Sasaki K., Wakamiya N., Ichikawa K., Atsumi T., Ohtani K., et al. Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjögren's syndrome. Genes Immun 2001, 2:99-104.
39. Liu R., Xu N., Wang X., Shen L., Zhao G., Zhang H., et al. Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis. Mol Biol Rep 2012, 10.1007/s11033-012-1518-y.
40. Stahl E.A., Raychaudhuri S., Remmers E.F., Xie G., Eyre S., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010, 42:508-514.
41. Barton A., Lamb R., Symmons D., Silman A., Thomson W., Worthington J., et al. Macrophage migration inhibitory factor gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun 2003, 4:487-491.
42. Baugh J.A., Bucala R. Macrophage migration inhibitory factor. Crit Care Med 2002, 30:S27-S35.
43. Renner P., Roger T., Bochud P.Y., Sprong T., Sweep F.C., Bochud M., et al. A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease. FASEB J 2012, 26:907-916.
44. Roger T., Ding X., Chanson A.L., Renner P., Calandra T. Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression. Eur J Immunol 2007, 37:3509-3521.
45. Sreih A., Ezzeddine R., Leng L., LaChance A., Yu G., Mizue Y., et al. Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. Arthritis Rheum 2011, 63:3942-3951.
46. Jensen P.H., Weilguny D., Matthiesen F., McGuire K.A., Shi L., Hojrup P. Characterization of the oligomer structure of recombinant human mannan-binding lectin. J Biol Chem 2005, 280:11043-11051.